Skip to main content

Aggregate Degradation for Alzheimer's

Sally Zhang  is a junior who is majoring in Biology. She was awarded a Fall 2018 Independent Grant which she used to conduct research on ubiquination and Alzheimer's disease under Dr. Hyojung Choo. 

I started doing my project at the Seyfried Lab of the Biochemistry department and Center for Neurodegenerative diseases of Emory School of Medicine in April 2018. My project aims to examine the mechanisms underlying the turnover of insoluble neurofibrillary tangles of Tau, a key type of pathological protein aggregate in Alzheimer’s disease. Alzheimer’s disease is characterized by the presence of protein aggregates and a loss of protein homeostasis. Ubiquitin (Ub) is a 76 amino acid peptide that marks proteins for degradation mainly through the ubiquitin-proteasome system (UPS) and autophagy. Modification by Lys-48-linked poly-Ub chains has been reported as means of selecting proteins for degradation by the UPS. Whereas, Lys-63-linked poly-ubiquitination is associated with the clearance of proteins by autophagy.



The project involves affinity capturing poly-ubiquitinated proteins by tandem ubiquitin binding entities, which has a nano-molar affinity for poly-ubiquitinated substrates. So far, we have used TUBE 1, which is captures all poly-Ub chains regardless of linkage type, and analyzed the affinity captured proteins by label-free mass spectrometry. After controlling for non-specific binding, we identified about 200 proteins that were at least two-fold enriched between control and AD cases. Several targets, such as Tau, p62/SQSTM1 and 14-3-3 proteins, which are known to be associated with AD have been identified as ubiquitinated more than two-fold compared to control. Compared to a previous study which I was a part of that was published in the journal, proteomics, over 50% of the above mentioned 200 or so proteins have increased site-specific levels of ubiquitination in AD brain. Compared to that same study, interestingly, we identified less ubiquitinated proteins. We hypothesize that the reason that there may be less identified may be due to the TUBEs’ preference for poly-ubiquitin chains whereas the di-Gly antibody used in that study can be used to identify all Ub molecules. 

It has been a challenging but rewarding experience for me. As someone who worked for two years in a microbiology lab and published a paper in PLoS One as the primary author in the same field, I found there to be quite a few key differences that were difficult to adjust to right away. For instance, differences in what to watch out for during sample preparation. There are different things to watch out for when working with different types of samples. When working with bacterial samples it is very important to make sure everything is sterile and kept under a fume food for experiments so that the samples will not be contaminated while these samples are not very sensitive to temperature. On the other hand, when dealing with brain tissue samples it is extremely important that samples are kept on ice. It felt somewhat strange to not work under a fume hood for almost all experiments initially. As well, at first I underestimated tissue samples’ sensitivity to temperature and ended up with not very ideal results for a while. I very much enjoyed trying research in a very different field. I think that it has been quite challenging but I was able to learn many interesting things. 

Visit  the Undergraduate Research Programs website to learn more about applying for Independent Research Grants.

Comments

Popular posts from this blog

Why Research Wednesday: Aamna's Story

Aamna Soniwala is a sophomore majoring in Human Health (on the pre-dental track) with a minor in Sociology. URP's Research Ambassador Arielle Segal had the pleasure of interviewing Aamna about her research experiences. Here it is:  What research do you do on campus? How long have you been doing it? “I work under Dr. K.M. Venkat Narayan with Dr. Jithin Varghese in the Hubert Department of Global Health at Rollins – specifically within the Emory Global Diabetes Research Center. I started during my second semester of my first year, researching global health equity in diabetes precision medicine.” How did you get started in your research? “I took HLTH 210 last spring, and Dr. Narayan was one of our asynchronous guest lecturers. I felt that I resonated with his values and research, so I reached out to him and started working with a post-doctoral fellow, Dr. Varghese.” How has research impacted your undergraduate career? “Research has allowed me to grow as a critical thinker and problem

A Whole New World of Research

Monica Vemulapalli is a junior majoring in Neuroscience and Behavioral Biology. She was awarded a Spring 2019 Conference Grant which she used to attend the Experimental Biology Conference . When I found out that my first ever research conference was going to be in my hometown of Orlando, Florida, I was excited! I knew that having an unfamiliar event happen at a very familiar place would make me less anxious. However, the conference turned out to be less stressful and more interesting than I ever thought. I attended  Experimental Biology (EB)  and   presented  my very first research poster , a memory that I will definitely cherish forever.

Why Research Wednesday: Katelyn King

  Katelyn King is a senior at Emory’s College of Arts and Sciences, majoring in Biology and minoring in Global Health, Culture & Society. Her research area is on c ancer biology, and she investigates the effects of knocking out anti-apoptotic genes on drug efficacy in multiple myeloma.   Her collegiate research journey started the summer after her first year. She was accepted into the NIH-NIDDK Short-Term Research Experience for Underrepresented Persons (STEP-UP) program and was tasked with finding a mentor. She reached out to Oxford Professor Dr. Taliaferro-Smith because SHE was interested in her triple-negative breast cancer (TNBC) research. After a brief informational interview, Dr. Taliaferro-Smith invited Katelyn to join her lab! During the 10-week program, SHE studied the effects of genetic modifications in TNBC. She offered to continue her position on the project throughout the academic year as an Oxford Research Scholar. She has since had the opportunity to conduct rese